X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare JUBILANT LIFE SCIENCES with Cadila Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs CADILA HEALTHCARE - Comparison Results

CADILA HEALTHCARE 
   Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES CADILA HEALTHCARE JUBILANT LIFE SCIENCES/
CADILA HEALTHCARE
 
P/E (TTM) x 12.9 13.5 95.5% View Chart
P/BV x 1.8 2.8 64.3% View Chart
Dividend Yield % 0.6 1.4 44.4%  

Financials

 JUBILANT LIFE SCIENCES   CADILA HEALTHCARE
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-18
CADILA HEALTHCARE
Mar-18
JUBILANT LIFE SCIENCES/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs1,039558 186.2%   
Low Rs600362 166.0%   
Sales per share (Unadj.) Rs482.6116.3 415.0%  
Earnings per share (Unadj.) Rs40.717.9 227.9%  
Cash flow per share (Unadj.) Rs67.423.1 291.2%  
Dividends per share (Unadj.) Rs3.003.50 85.7%  
Dividend yield (eoy) %0.40.8 48.1%  
Book value per share (Unadj.) Rs262.385.4 307.1%  
Shares outstanding (eoy) m155.791,023.74 15.2%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.74.0 43.0%   
Avg P/E ratio x20.125.7 78.2%  
P/CF ratio (eoy) x12.219.9 61.2%  
Price / Book Value ratio x3.15.4 58.0%  
Dividend payout %7.419.6 37.6%   
Avg Mkt Cap Rs m127,670470,664 27.1%   
No. of employees `0002.411.8 20.6%   
Total wages/salary Rs m15,55918,545 83.9%   
Avg. sales/employee Rs Th30,861.410,072.7 306.4%   
Avg. wages/employee Rs Th6,387.01,569.1 407.1%   
Avg. net profit/employee Rs Th2,604.41,547.7 168.3%   
INCOME DATA
Net Sales Rs m75,178119,049 63.1%  
Other income Rs m4001,132 35.4%   
Total revenues Rs m75,579120,181 62.9%   
Gross profit Rs m15,18428,475 53.3%  
Depreciation Rs m4,1515,388 77.0%   
Interest Rs m2,843911 312.1%   
Profit before tax Rs m8,59123,308 36.9%   
Minority Interest Rs m0628 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,2475,644 39.8%   
Profit after tax Rs m6,34418,292 34.7%  
Gross profit margin %20.223.9 84.4%  
Effective tax rate %26.224.2 108.0%   
Net profit margin %8.415.4 54.9%  
BALANCE SHEET DATA
Current assets Rs m31,89882,005 38.9%   
Current liabilities Rs m20,04760,720 33.0%   
Net working cap to sales %15.817.9 88.2%  
Current ratio x1.61.4 117.8%  
Inventory Days Days6873 92.4%  
Debtors Days Days5598 55.8%  
Net fixed assets Rs m60,71583,703 72.5%   
Share capital Rs m1561,024 15.2%   
"Free" reserves Rs m40,71086,421 47.1%   
Net worth Rs m40,86587,445 46.7%   
Long term debt Rs m30,47825,551 119.3%   
Total assets Rs m96,176180,653 53.2%  
Interest coverage x4.026.6 15.1%   
Debt to equity ratio x0.70.3 255.2%  
Sales to assets ratio x0.80.7 118.6%   
Return on assets %9.610.6 89.9%  
Return on equity %15.520.9 74.2%  
Return on capital %16.022.0 72.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m14,40242,683 33.7%   
Fx outflow Rs m12,04411,242 107.1%   
Net fx Rs m2,35831,441 7.5%   
CASH FLOW
From Operations Rs m13,0329,193 141.8%  
From Investments Rs m-6,177-9,737 63.4%  
From Financial Activity Rs m-9,011515 -1,749.8%  
Net Cashflow Rs m-2,123-29 7,319.3%  

Share Holding

Indian Promoters % 45.6 74.8 61.0%  
Foreign collaborators % 3.5 0.0 -  
Indian inst/Mut Fund % 8.7 8.3 104.8%  
FIIs % 21.2 5.9 359.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.1 11.0 191.8%  
Shareholders   23,815 44,069 54.0%  
Pledged promoter(s) holding % 15.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   VENUS REMEDIES  ORCHID PHARMA LTD  SANOFI INDIA  J.B.CHEMICALS  SHASUN PHARMA  

Compare JUBILANT LIFE SCIENCES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Flat; Capital Goods and Realty Stocks Lag(09:30 am)

Asian share markets are mixed today. The Shanghai Composite is lower by 0.3% while the Hang Seng is even. The Nikkei 225 is trading down by 0.7%.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 21.0% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 21.0% YoY). Sales on the other hand came in at Rs 37 bn (up 14.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY19); Net Profit Down 166.0% (Quarterly Result Update)

May 21, 2019 | Updated on May 21, 2019

For the quarter ended March 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 1 bn (down 166.0% YoY). Sales on the other hand came in at Rs 24 bn (up 5.9% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

CADILA HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 3.7% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 3.7% YoY). Sales on the other hand came in at Rs 36 bn (up 9.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (3QFY19); Net Profit Up 25.7% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, JUBILANT LIFE SCIENCES has posted a net profit of Rs 3 bn (up 25.7% YoY). Sales on the other hand came in at Rs 24 bn (up 15.0% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

More Views on News

Most Popular

I Believe this is the Best Stock to Buy Today(Profit Hunter)

Jul 3, 2019

The languishing small cap space is currently offering a very fertile market to pick up bargains at very attractive prices. This is a perfect opportunity ripe for the picking.

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound(Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors(The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Union Budget 2019-2020: More Style Over Substance(The 5 Minute Wrapup)

Jul 5, 2019

Did the Union Budget announce measures to stimulate the economy and bolster corporate earnings growth?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Jul 16, 2019 11:43 AM

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES 5-YR ANALYSIS

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS